Advertisement
Screener

ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) ROE

ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) ROE

  • 2026-06-30: ROE 12.93%.
  • 2026-03-31: ROE -1.25%.
  • 2025-12-31: ROE -8.52%.
  • 2025-09-30: ROE -28.04%.

Complete source-backed roe history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3012.93%
2026-03-31-1.25%
2025-12-31-8.52%
2025-09-30-28.04%
2025-06-30-67.11%
2025-03-31-90.93%
2024-12-31-88.89%
2024-09-30-124.83%
2024-06-30-106.62%
2024-03-31-96.66%
2023-12-31-295.65%
2023-09-30-573.40%
2023-06-30-410.91%
2023-03-31-234.19%
2022-12-31-148.61%
2022-09-30-114.77%
2022-06-30-133.09%
2022-03-31-92.46%
2021-12-31-69.32%
2021-09-30-46.58%
2021-06-30-36.26%
2021-03-31-31.86%
2020-12-31-50.14%
2020-09-30-65.98%
2020-06-30-43.30%
2020-03-31-26.19%
2019-12-3164.58%

Annual ROE

DateROE
2025-12-31-8.52%
2024-12-31-88.89%
2023-12-31-295.65%
2022-12-31-148.61%
2021-12-31-69.32%
2020-12-31-50.14%
2019-12-3164.58%
2018-12-3180.27%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
AbCellera Biologics Inc. (ABCL)$3.879B-14.59